Transthyretin-related familial amyloid cardiomyopathy (Q90631): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/821512398 / rank
 
Normal rank

Revision as of 17:37, 15 August 2026

Transthyretin (TTR)-related familial amyloid cardiomyopathy is a hereditary TTR-related systemic amyloidosis with predominant cardiac involvement resulting from myocardial infiltration of abnormal amyloid protein (an insoluble fibrillar protein). Additional information. The TTR gene on chromosome 18q12.1 encompasses over 100 single nucleotide polymorphisms with over 80 confirmed pathogenic autosomal dominant mutations and geographic and-or ethnic groupings. The clinical phenotype varies greatly with the mutation, the age of onset, disease penetrance, clinical course, and prognosis. Extracardiac manifestations include sensory neuropathy, autonomic dysfunction, and carpal tunnel syndrome.
Language Label Description Also known as
default for all languages
ID_821512398
    English
    Transthyretin-related familial amyloid cardiomyopathy
    Transthyretin (TTR)-related familial amyloid cardiomyopathy is a hereditary TTR-related systemic amyloidosis with predominant cardiac involvement resulting from myocardial infiltration of abnormal amyloid protein (an insoluble fibrillar protein). Additional information. The TTR gene on chromosome 18q12.1 encompasses over 100 single nucleotide polymorphisms with over 80 confirmed pathogenic autosomal dominant mutations and geographic and-or ethnic groupings. The clinical phenotype varies greatly with the mutation, the age of onset, disease penetrance, clinical course, and prognosis. Extracardiac manifestations include sensory neuropathy, autonomic dysfunction, and carpal tunnel syndrome.

      Statements